PDS Planning’s Biogen BIIB Stock Holding History

PDS Planning’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	1,310 +16	+1%	+$3.06K	0.02%	446
2026 Q1	$237K	Buy	1,294 +3	+0.2%	+$553	0.02%	464
2025 Q4	$227K	Buy	+1,291	New	+$211K	0.02%	472

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PDS Planning's BIIB Position: Q2 2026 in Review

PDS Planning increased its Biogen (BIIB) stake by 1.2% in Q2 2026, buying an estimated $3.06K and bringing the position to 1,310 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #446.

PDS Planning first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

PDS Planning held 1,310 shares of Biogen worth $283K as of Q2 2026.
PDS Planning bought 16 Biogen shares in Q2 2026, an estimated $3.06K.
Biogen made up 0.02% of PDS Planning's portfolio in Q2 2026, its #446 holding.
PDS Planning first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.